on hepatitis C
A team of researchers at the Beirne
B. Carter Center for Immunology Research recently received
a $660,000 grant from the Chicago-based Dr. Ralph and Marion Falk
Medical Research Trust, to develop treatments and vaccines for
hepatitis C and to help establish an international research center.
Hepatitis C infection, a chronic form of hepatitis caused by a
virus, is spread by blood, generally through unprotected sex or
needle sharing. Roughly 4 million Americans are infected, making
hepatitis C the most common blood-borne infection. Although screening
tests exist, most people are unaware they are infected until they
are diagnosed with liver failure or liver cancer. Treatments suppress
the virus in only a small number of patients.